"Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.

Montopoli, M

"Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. [electronic resource] - Current cancer drug targets Feb 2011 - 226-35 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1873-5576

10.2174/156800911794328501 doi


Antineoplastic Agents--metabolism
Apoptosis--drug effects
Carcinoma--drug therapy
Cell Line, Tumor
Cisplatin--metabolism
Cytoplasmic Granules--drug effects
DNA, Mitochondrial--genetics
Drug Resistance, Neoplasm
Female
Glucose--metabolism
Glutathione--metabolism
Humans
Inhibitory Concentration 50
Lipid Metabolism--drug effects
Membrane Potential, Mitochondrial--drug effects
Mitochondria--drug effects
Oligomycins--pharmacology
Ovarian Neoplasms--drug therapy
Oxidative Phosphorylation--drug effects
Oxygen Consumption--drug effects
Rotenone--pharmacology
Uncoupling Agents--pharmacology